UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 544

Sortiert nach

Targeted therapy in cancer

Cancer Chemotherapy and Pharmacology, 2015-12, Vol.76 (6), p.1113-1132

Tsimberidou, Apostolia-Maria

2015

Link zum Volltext

Verfügbarkeit prüfen

Review of precision cancer medicine: Evolution of the treatment paradigm

Cancer treatment reviews, 2020-06, Vol.86, p.102019-102019, Article 102019

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical trial design in the era of precision medicine

Genome medicine, 2022-08, Vol.14 (1), p.1-101, Article 101

2022

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomics and solid tumors: The next frontier in precision cancer medicine

Seminars in cancer biology, 2022-09, Vol.84, p.50-59

2022

Link zum Volltext

Verfügbarkeit prüfen

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

Clinical cancer research, 2017-03, Vol.23 (6), p.1388-1396

2017

Link zum Volltext

Verfügbarkeit prüfen

Precision medicine: lessons learned from the SHIVA trial

The lancet oncology, 2015-12, Vol.16 (16), p.e579-e580

2015

Link zum Volltext

Verfügbarkeit prüfen

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Clinical cancer research, 2012-11, Vol.18 (22), p.6373-6383

2012

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

Journal of clinical oncology, 2018-06, Vol.36 (16), p.1631-1641

2018

Link zum Volltext

Verfügbarkeit prüfen

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists

The Journal of molecular diagnostics : JMD, 2017-01, Vol.19 (1), p.4-23

2017

Link zum Volltext

Verfügbarkeit prüfen

Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers

Clinical cancer research, 2018-01, Vol.24 (1), p.181-188

2018

Link zum Volltext

Verfügbarkeit prüfen

Correlation between biomarkers and treatment outcomes in diverse cancers: a systematic review and meta-analysis of phase I and II immunotherapy clinical trials

European journal of cancer (1990), 2023-08, Vol.189, p.112927-112927, Article 112927

2023

Link zum Volltext

Verfügbarkeit prüfen

Innovative trial design in precision oncology

Seminars in cancer biology, 2022-09, Vol.84, p.284-292

2022

Link zum Volltext

Verfügbarkeit prüfen

Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (13), p.3690-3701

2016

Link zum Volltext

Verfügbarkeit prüfen

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers

PloS one, 2011-07, Vol.6 (7), p.e22769-e22769

2011

Link zum Volltext

Verfügbarkeit prüfen

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials

JNCI : Journal of the National Cancer Institute, 2016-04, Vol.108 (4), p.djv362

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors

Cell reports (Cambridge), 2014-01, Vol.6 (2), p.377-387

2014

Link zum Volltext

Verfügbarkeit prüfen

Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits

Expert opinion on investigational drugs, 2018-02, Vol.27 (2), p.155-162

2018

Link zum Volltext

Verfügbarkeit prüfen

Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design

Cancer treatment reviews, 2024-04, Vol.125, p.102703-102703, Article 102703

2024

Link zum Volltext

Verfügbarkeit prüfen

PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations

Journal of clinical oncology, 2012-03, Vol.30 (8), p.777-782

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers

Molecular cancer therapeutics, 2018-07, Vol.17 (7), p.1595-1601

2018

Link zum Volltext

Verfügbarkeit prüfen

T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors

Journal of hematology and oncology, 2021-06, Vol.14 (1), p.102-102, Article 102

2021

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor DNA analysis in the era of precision oncology

Oncotarget, 2020-01, Vol.11 (2), p.188-211

2020

Link zum Volltext

Verfügbarkeit prüfen

MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study

The lancet oncology, 2014-05, Vol.15 (6), p.656-666

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies

Expert opinion on drug metabolism & toxicology, 2014-03, Vol.10 (3), p.483-494

2014

Link zum Volltext

Verfügbarkeit prüfen

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

Nature Medicine, 2019-05, Vol.25 (5), p.751-758

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 544

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(452)
Mit Volltextzugriff
(518)

Publikationsform

Sprache

Englisch
(544)
Japanisch
(30)

Erscheinungsjahr

n.n

Thema

Science & Technology
(265)
Life Sciences & Biomedicine
(259)
Oncology
(234)
Humans
(206)
Female
(134)
Middle Aged
(132)
Male
(129)
Aged
(116)
Adult
(111)
Treatment Outcome
(67)
Tumors
(66)
Neoplasms - Drug Therapy
(64)
Aged, 80 And Over
(60)
Patients
(58)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(53)
Cancer
(53)
Mutation
(52)
Clinical Trials
(51)
Biological And Medical Sciences
(47)
Medical Sciences
(47)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(118)
Cancer Research
(47)
Oncotarget
(27)
Blood
(24)
Molecular Cancer Therapeutics
(23)
Cancer Chemotherapy And Pharmacology
(22)
Clinical Cancer Research
(19)
Investigational New Drugs
(16)
Leukemia & Lymphoma
(11)
The Oncologist
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Targeted therapy in cancer

Review of precision cancer medicine: Evolution of the treatment paradigm

Clinical trial design in the era of precision medicine

Transcriptomics and solid tumors: The next frontier in precision cancer medicine

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

Precision medicine: lessons learned from the SHIVA trial

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists

Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers

Correlation between biomarkers and treatment outcomes in diverse cancers: a systematic review and meta-analysis of phase I and II immunotherapy clinical trials

Innovative trial design in precision oncology

Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials

Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors

Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits

Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design

PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations

Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers

T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors

Circulating tumor DNA analysis in the era of precision oncology

MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study

Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

Aktive Filter

Suchergebnisse filtern